TOP TIERMARKET NEWSWIRE

News & sentiment

GOSSAMER BIO INC (GOSS) — News & AI sentiment

GOSSAMER BIO INC (GOSS) news roundup. 7 stories in the past week, 21 over 30 days. Average 30-day sentiment is 39.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

7

avg sentiment 39.3/100

30d stories

21

avg sentiment 39.2/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

GOSS news in the last 24 hours, 7 days, 30 days and 90 days

How much GOSS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	GOSS stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	7	39.3/100	GOSS headlines →
Last 30 days	21	39.2/100	GOSS headlines →
Last 90 days	40	46.8/100	GOSS headlines →

Latest stories on GOSS

Gossamer Bio Executes Reverse Stock Split and Share Reduction

TipRanks25 · bearishgeneral

2d ago

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

2d ago

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

StockTitan25 · bearishgeneral

2d ago

Gossamer Bio trading halted, news pending

The Fly50 · neutralgeneral

3d ago

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

4d ago

Gossamer Bio Announces 1-for-80 Reverse Stock Split

StockTitan25 · bearishgeneral

4d ago

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

GlobeNewswire50 · neutralgeneral

5d ago

Gossamer Bio to Present at Cantor Global Healthcare Conference

StockTitan56 · neutralproduct/pr

Sep 4

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

Sep 3

Gossamer (GOSS) Announced Up to $250M of Financing, but Only $25M is Expected Upfront. Is the Runway Secure?

Yahoo Top38 · neutralgeneral

Aug 27

H.C. Wainwright reiterates Gossamer Bio stock rating on NDA progress

Investing.com Analyst Ratings56 · neutralanalyst

Aug 27

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

Aug 26

Gossamer Bio announces $250m in funding to advance seralutinib

Yahoo Finance24 · bearishgeneral

Aug 24

Gossamer Bio Secures Up to $250 Million Private Placement to Fund Seralutinib Through Potential FDA Approval

InvestorsHub24 · bearishgeneral

Aug 21

Gossamer Bio announces up to $250M private placement

Seeking Alpha28 · bearishgeneral

Aug 21

Gossamer Bio Secures Major Seralutinib Regulatory Financing Deal

TipRanks58 · neutralgeneral

Aug 21

Gossamer Bio announces upt to $250M structured private placement

The Fly28 · bearishgeneral

Aug 21

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

Aug 21

Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval

StockTitan24 · bearishgeneral

Aug 21

Gossamer Bio reports Q2 EPS (8c), consensus (12c)

The Fly34 · bearishearnings

Aug 16

Gossamer Bio price target lowered to $4 from $15 at Piper Sandler

The Fly28 · bearishanalyst

Aug 16

Gossamer Bio GAAP EPS of -$0.08 beats by $0.06, revenue of $9.24M beats by $5.61M

Seeking Alpha58 · neutralearnings

Aug 13

Gossamer Bio, Inc. (GOSS) files 8-K

SEC 8-K50 · neutralgeneral

Aug 13

Gossamer Bio Announces Second Quarter 2026 Financial Results and Provides Business Update

StockTitan59 · neutralgeneral

Aug 13

Kuehn Law Encourages Investors of Gossamer Bio, Inc. to Contact Law Firm

PR Newswire42 · neutralgeneral

Aug 10

Open GOSS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →